Connect with us

Healthcare

Ebola Drug Remdesivir Shows Early Signs Of Hope In Treating COVID Patients

Published

on

A drug used to treat Ebola patients, Redesivir, is showing signs of hope against the COVID-19 virus in early trials, according to a press release from biopharmaceutical company Gilead Sciences.

The drug is also used for Marburg, MERS and SARS viruses.

“Unlike traditional drug development, we are attempting to evaluate an investigational agent alongside an evolving global pandemic. Multiple concurrent studies are helping inform whether remdesivir is a safe and effective treatment for COVID-19 and how to best utilize the drug,” said Merdad Parsey, MD, PhD, Chief Medical Officer, Gilead Sciences in a statement released Wednesday.

The statement continued, “These study results complement data from the placebo-controlled study of remdesivir conducted by the National Institute for Allergy and Infectious Diseases and help to determine the optimal duration of treatment with remdesivir. The study demonstrates the potential for some patients to be treated with a 5-day regimen, which could significantly expand the number of patients who could be treated with our current supply of remdesivir. This is particularly important in the setting of a pandemic, to help hospitals and healthcare workers treat more patients in urgent need of care.”

The trial found that patients who received a 5-day dosage of the medication showed similar signs of improvement compared to a 10-day dosage. More than half of the patients treated early on in their diagnosis were discharged from the hospital before 14 days, according to the release.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Healthcare

Study finds harmful levels of ‘forever chemicals’ in popular bandage brands

Published

on

GettyImages 1741522655 scaled

A new consumer study tested several brands of bandages and found higher levels of fluorine in bandages from Band-Aid, CVS Health, Walmart, Rite Aid, Target and Curad, which contain harmful levels of “forever chemicals,” also known as PFAS.

The study by Mamavation and Environmental Health News revealed that out of 40 bandages from 18 different brands, 26 contained organic fluorine, an indicator of PFAS.

“Because bandages are placed upon open wounds, it’s troubling to learn that they may be also exposing children and adults to PFAS,” said Dr. Linda S. Birnbaum, the study’s co-author and the former director of the National Institute of Environmental Health Sciences and National Toxicology Program.

News Nation reports that the study found the chemicals present in the adhesive part of the bandages. Mamavation said some brands likely used the PFAS in bandages “for their waterproof qualities.”

“It’s obvious from the data that PFAS are not needed for wound care, so it’s important that the industry remove their presence to protect the public from PFAS and opt instead for PFAS-free materials,” Birnbaum said.

According to the study, the chemicals are linked to several health effects, including “reduced immune system, vaccine response, developmental and learning problems for infants and children, certain cancers, lowered fertility, and endocrine disruption.”

While the exposure risk to PFAS through the skin isn’t clear, skin exposure “poses similar health risks” as eating or drinking food contaminated with PFAS, according to a previous study by the National Institute for Occupational Safety and Health.

Continue Reading

Trending